These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29466231)

  • 1. Transcytosis of payloads that are non-covalently complexed to bispecific antibodies across the hCMEC/D3 blood-brain barrier model.
    Schmid D; Buntz A; Hanh Phan TN; Mayer K; Hoffmann E; Thorey I; Niewöhner J; Vasters K; Sircar R; Mundigl O; Kontermann RE; Brinkmann U
    Biol Chem; 2018 Jun; 399(7):711-721. PubMed ID: 29466231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracellular sorting and transcytosis of the rat transferrin receptor antibody OX26 across the blood-brain barrier in vitro is dependent on its binding affinity.
    Haqqani AS; Thom G; Burrell M; Delaney CE; Brunette E; Baumann E; Sodja C; Jezierski A; Webster C; Stanimirovic DB
    J Neurochem; 2018 Sep; 146(6):735-752. PubMed ID: 29877588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A human blood-brain barrier transcytosis assay reveals antibody transcytosis influenced by pH-dependent receptor binding.
    Sade H; Baumgartner C; Hugenmatter A; Moessner E; Freskgård PO; Niewoehner J
    PLoS One; 2014; 9(4):e96340. PubMed ID: 24788759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Perfused In Vitro Human iPSC-Derived Blood-Brain Barrier Faithfully Mimics Transferrin Receptor-Mediated Transcytosis of Therapeutic Antibodies.
    Burgio F; Gaiser C; Brady K; Gatta V; Class R; Schrage R; Suter-Dick L
    Cell Mol Neurobiol; 2023 Nov; 43(8):4173-4187. PubMed ID: 37698826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs.
    Pornnoppadol G; Bond LG; Lucas MJ; Zupancic JM; Kuo YH; Zhang B; Greineder CF; Tessier PM
    Cell Chem Biol; 2024 Feb; 31(2):361-372.e8. PubMed ID: 37890480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
    Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
    Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
    De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
    J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain penetration, target engagement, and disposition of the blood-brain barrier-crossing bispecific antibody antagonist of metabotropic glutamate receptor type 1.
    Webster CI; Caram-Salas N; Haqqani AS; Thom G; Brown L; Rennie K; Yogi A; Costain W; Brunette E; Stanimirovic DB
    FASEB J; 2016 May; 30(5):1927-40. PubMed ID: 26839377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Brain uptake of multivalent and multi-specific DVD-Ig proteins after systemic administration.
    Karaoglu Hanzatian D; Schwartz A; Gizatullin F; Erickson J; Deng K; Villanueva R; Stedman C; Harris C; Ghayur T; Goodearl A
    MAbs; 2018 Jul; 10(5):765-777. PubMed ID: 29771629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A single-chain fragment constant design enables easy production of a monovalent blood-brain barrier transporter and provides an improved brain uptake at elevated doses.
    Morrison JI; Metzendorf NG; Rofo F; Petrovic A; Hultqvist G
    J Neurochem; 2023 May; 165(3):413-425. PubMed ID: 36681883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target.
    Yu YJ; Zhang Y; Kenrick M; Hoyte K; Luk W; Lu Y; Atwal J; Elliott JM; Prabhu S; Watts RJ; Dennis MS
    Sci Transl Med; 2011 May; 3(84):84ra44. PubMed ID: 21613623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the transcytosis of an anti-transferrin receptor antibody with a Fab' cargo across the blood-brain barrier in mice.
    Manich G; Cabezón I; del Valle J; Duran-Vilaregut J; Camins A; Pallàs M; Pelegrí C; Vilaplana J
    Eur J Pharm Sci; 2013 Jul; 49(4):556-64. PubMed ID: 23748097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mathematical PKPD and safety model of bispecific TfR/BACE1 antibodies for the optimization of antibody uptake in brain.
    Gadkar K; Yadav DB; Zuchero JY; Couch JA; Kanodia J; Kenrick MK; Atwal JK; Dennis MS; Prabhu S; Watts RJ; Joseph SB; Ramanujan S
    Eur J Pharm Biopharm; 2016 Apr; 101():53-61. PubMed ID: 26820920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Investigating receptor-mediated antibody transcytosis using blood-brain barrier organoid arrays.
    Simonneau C; Duschmalé M; Gavrilov A; Brandenberg N; Hoehnel S; Ceroni C; Lassalle E; Kassianidou E; Knoetgen H; Niewoehner J; Villaseñor R
    Fluids Barriers CNS; 2021 Sep; 18(1):43. PubMed ID: 34544422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hapten-directed spontaneous disulfide shuffling: a universal technology for site-directed covalent coupling of payloads to antibodies.
    Dengl S; Hoffmann E; Grote M; Wagner C; Mundigl O; Georges G; Thorey I; Stubenrauch KG; Bujotzek A; Josel HP; Dziadek S; Benz J; Brinkmann U
    FASEB J; 2015 May; 29(5):1763-79. PubMed ID: 25670234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Engineered hapten-binding antibody derivatives for modulation of pharmacokinetic properties of small molecules and targeted payload delivery.
    Dengl S; Sustmann C; Brinkmann U
    Immunol Rev; 2016 Mar; 270(1):165-77. PubMed ID: 26864111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferrin receptor (TfR) trafficking determines brain uptake of TfR antibody affinity variants.
    Bien-Ly N; Yu YJ; Bumbaca D; Elstrott J; Boswell CA; Zhang Y; Luk W; Lu Y; Dennis MS; Weimer RM; Chung I; Watts RJ
    J Exp Med; 2014 Feb; 211(2):233-44. PubMed ID: 24470444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro Blood-Brain barrier model based on recombinant spider silk protein nanomembranes for evaluation of transcytosis capability of biomolecules.
    Hjelm LC; Hedhammar M; Löfblom J
    Biochem Biophys Res Commun; 2023 Aug; 669():77-84. PubMed ID: 37267863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcytosis of protein through the mammalian cerebral epithelium and endothelium. III. Receptor-mediated transcytosis through the blood-brain barrier of blood-borne transferrin and antibody against the transferrin receptor.
    Broadwell RD; Baker-Cairns BJ; Friden PM; Oliver C; Villegas JC
    Exp Neurol; 1996 Nov; 142(1):47-65. PubMed ID: 8912898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody screening using a human iPSC-based blood-brain barrier model identifies antibodies that accumulate in the CNS.
    Georgieva JV; Goulatis LI; Stutz CC; Canfield SG; Song HW; Gastfriend BD; Shusta EV
    FASEB J; 2020 Sep; 34(9):12549-12564. PubMed ID: 32960493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.